Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-17-067229

CFO and Secretary sold 26,165 shares at $1.13 ($29,566)

From the SEC's structured data for this filing

Trades in this filing

KENYON LAWRENCE A · CFO and Secretary

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-12-22 Sale : show line 1 in the form −26,165 $1.13 $29,566 67,313 D
Open-market sales · 26,165 sh · avg $1.13 · $29,566
Loading xslF345X03/doc4.xml…